TY  - JOUR

T1  - Dupilumab Safety and Efficacy Up to 3 Years Across Racial Subgroups in Pediatric Patients Aged 6 Months to 11 Years With Atopic Dermatitis

JO  - Journal of Investigative Dermatology

UR  - https://doi.org/10.1016/s0022-202x(26)00603-2

PY  - 2026/03/01

AU  - Siegfried E

AU  - Cork M

AU  - Gonzalez M

AU  - Aschoff R

AU  - Alexis A

AU  - Aldredge L

AU  - Chen Z

AU  - Prescilla R

AU  - Nguyen T

ED  - 

DO  - DOI: 10.1016/s0022-202x(26)00603-2

PB  - Elsevier BV

VL  - 146

IS  - 3

SP  - S17

EP  - S17

Y2  - 2026/03/16

ER  -